Overview

Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.

Status:
Recruiting

Trial end date:
2023-09-01

Target enrollment:

Participant gender:

Summary

It is a randomised, double-blinded clinical trial in which consenting participants who meet the inclusion criteria would be randomised into 2 groups. Subjects will be given either preserved or preservative free latanoprost for a period of 12 weeks. The efficacy and tolerability of both drugs would be assessed every 4 weeks, amongst these patients.

Phase:

Phase 4

Details

Lead Sponsor:

Uzoma Chinyei Joan

Treatments:

Latanoprost
Ophthalmic Solutions